Collagen wound healing matrices and process for their production
Collagen implants that are useful as wound healing matrices are characterized by being formed of collagen fibrils that are not chemically cross-linked, and having a bulk density of 0.01 to 0.3 g/cm3 and a pore population in which at least about 80% of the pores have an average pore size of 35 to 250...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
21.08.1990
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Collagen implants that are useful as wound healing matrices are characterized by being formed of collagen fibrils that are not chemically cross-linked, and having a bulk density of 0.01 to 0.3 g/cm3 and a pore population in which at least about 80% of the pores have an average pore size of 35 to 250 microns. The implants are capable of promoting connective tissue deposition, angiogenesis, reepithelialization, and fibroplasia. The wound healing matrix also serves an an effective sustained delivery system for synergistic combinations of FGF and TGF-B. |
---|---|
Bibliography: | Application Number: US19880286303 |